EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing biogenic nanoparticles for combating antibiotic resistance: green synthesis, mechanistic insights, and biotechnological applications

Emad M Abdallah, Abdulrahman Mohammed Alhudhaibi, Ibrahim Mohammed Hussaini, Asmau Nna Sulaiman

Frontiers in Bioengineering and Biotechnology · 26.03.2026 · 14

DOI: 10.3389/fbioe.2026.1752199 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 26.03.2026. Verfasst von Emad M Abdallah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, Qassim University, Buraydah, Saudi Arabia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) continues to escalate worldwide, reducing the effectiveness of existing antibiotics and leading to an urgent need for alternative antimicrobial strategies. Biogenic nanoparticles (BNPs) are nanomaterials synthesized using plants, microorganisms, algae, or isolated biomolecules through biologically mediated processes. These green synthesis routes typically produce nanoparticles that are naturally capped with biological compounds such as phytochemicals, proteins, or polysaccharides, which can influence particle stability, surface chemistry, and biological interactions. The current review summarizes recent advances in the biosynthesis of BNPs, focusing on how biological metabolites regulate metal ion reduction, nucleation, growth, and stabilization, thereby shaping nanoparticle size, morphology, and antimicrobial behavior. BNPs including silver, gold, copper oxide, zinc oxide, iron oxide, titanium dioxide, and selenium have been widely investigated for antibacterial activity. Experimental studies indicate that these materials can act through multiple mechanisms, such as disruption of bacterial membranes, generation of reactive oxygen species, interference with metabolic processes, damage to DNA and proteins, inhibition of quorum sensing, and suppression of biofilm formation. Reported activity spans several WHO-priority and ESKAPE pathogens, largely based on in vitro studies and a limited number of preclinical in vivo models. BNPs have also been explored as adjunct platforms in combination with antibiotics, essential oils, or phytochemicals, where synergistic effects may reduce required drug concentrations and improve activity against resistant strains. In parallel, their physicochemical tunability has supported experimental applications in wound-related systems, antimicrobial coatings, drug delivery research, biosensing, and food-packaging materials. Despite these encouraging findings, major challenges remain. Variability in green synthesis protocols leads to inconsistent physicochemical properties, scalability remains limited, and comprehensive long-term toxicological, pharmacokinetic, and environmental safety data are still lacking. Addressing these issues is essential before BNP-based strategies can progress toward regulatory evaluation and clinical use. In conclusion, biogenic nanoparticles represent a promising but still experimental platform that may contribute to future antimicrobial development if supported by standardized synthesis, rigorous safety assessment, and translational research.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial resistancebiomedical applicationsdrug discoverygreen synthesismechanistic insightsmicroorganismsnanotechnologyphytochemicals

Autor:innen und Institutionen

  • Department of Biology, College of Science, Qassim University, Buraydah, Saudi Arabia.
  • Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
  • Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University Zaria, Zaria, Nigeria.

Zitieren

APA

Abdallah, E. M., Alhudhaibi, A. M., Hussaini, I. M., & Sulaiman, A. N. (2026). Harnessing biogenic nanoparticles for combating antibiotic resistance: green synthesis, mechanistic insights, and biotechnological applications. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1752199

Vancouver

Abdallah EM, Alhudhaibi AM, Hussaini IM, Sulaiman AN. Harnessing biogenic nanoparticles for combating antibiotic resistance: green synthesis, mechanistic insights, and biotechnological applications. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1752199

BibTeX
@article{Abdallah2026,
  author = {Abdallah, Emad M and Alhudhaibi, Abdulrahman Mohammed and Hussaini, Ibrahim Mohammed and Sulaiman, Asmau Nna},
  title = {Harnessing biogenic nanoparticles for combating antibiotic resistance: green synthesis, mechanistic insights, and biotechnological applications},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fbioe.2026.1752199}
}
Kostenlos starten →